期刊文献+

三氧化二砷对T急淋白血病及DNA转甲基酶1的影响

Effect of Arsenic Trioxide on Acute T-Lymphocytic Leukemia and DNA methyltransferase 1
下载PDF
导出
摘要 【目的】本研究旨在探索三氧化二砷(ATO)对急性T淋巴细胞白血病(T-ALL)细胞中DNA转甲基酶1(DNMT1)表达的影响及其抗白血病作用机制。【方法】体外培养T-ALL细胞株(Jurkat、CCRF-CEM、Molt-4),依据不同ATO干预浓度,分为对照组(0μmol/L)、低浓度组(3μmol/L)、高浓度组(6μmol/L),应用RT-qPCR和western blot研究ATO(0、3、6μmol/L)干预24 h后细胞内DNMT1和cleaved-caspase-3表达的变化;应用流式细胞术测定T ALL细胞系(Jurkat、CCRF-CEM、MOLT-4)的细胞死亡率;在ATO的干预下,应用Z-DEVD-FMK后检测DNMT1和cleaved-caspase-3表达和细胞死亡率的变化;在ATO的干预下,过表达DNMT1检测T-ALL细胞死亡率的变化。【结果】随着ATO浓度的增加,T-ALL细胞DNMT1表达水平降低,cleaved-caspase-3蛋白表达水平增加,细胞死亡率增加,差异具有统计学意义(P<0.05);应用Z-DEVD-FMK后可特异性抑制cleaved-caspase-3,减弱ATO对DNMT1表达的抑制作用,降低细胞死亡率,差异具有统计学意义(P<0.05);在T-ALL细胞中过表达DNMT1可显著降低ATO处理后诱导的细胞死亡,差异具有统计学意义(P<0.05)。【结论】在一定浓度范围内,ATO可通过激活caspase-3有效抑制DNMT1的表达从而诱导T-ALL细胞死亡,为未来ATO作为去甲基化药物应用于提高T-ALL的临床治疗提供了一定的理论依据。 【Objective】To explore the effect of arsenic trioxide(ATO)on the expression of DNA methyltransferase 1(DNMT1)and its anti-leukemia mechanism in acute T-lymphocytic leukemia(T-ALL)cells.【Methods】T-ALL cell lines(Jurkat,CCRF-CEM,Molt-4)were cultured in vitro and divided into control(0μmol/L),low concentration(3μmol/L)and high concentration(6μmol/L)groups according to the dose of ATO,and the expression of DNMT1 and cleaved-caspase-3 were investigated by RT-qPCR and western blot after ATO treatment for 24 h(0,3 and 6μmol/L)in⁃tervention;Flow cytometry was applied to detect cell death in T-ALL cell lines(Jurkat,CCRF-CEM,MOLT-4);The ex⁃pression of DNMT1 and cleaved-caspase-3 and cell death were detected after applying ATO and Z-DEVD-FMK(caspase 3 specific inhibitor);T-ALL cell death was detected after overexpressing DNMT1 under ATO intervention.【Results】With the dose of ATO increasing,the expression level of DNMT1 in T-ALL cells decreased,the expression level of cleaved-cas⁃pase-3 protein increased,and the cell mortality increased(P<0.05);The application of Z-DEVD-FMK specifically inhib⁃ited cleaved-caspase-3,diminished the inhibitory effect of ATO on DNMT1 expression,and decreased the cell mortality(P<0.05);Overexpression of DNMT1 in T-ALL cells significantly reduced cell death induced by ATO treatment(P<0.05).【Conclusion】Within a certain concentration range,ATO effectively down-regulates the expression of DNMT1 via the acti⁃vation of caspase-3 in a dose-dependent manner,thus inducing cell death in T-ALL cells,which provides a theoretical basis for the future application of ATO as a demethylating drug to improve the clinical treatment of T-ALL.
作者 苏嘉茵 吴忠道 罗学群 SU Jia-yin;WU Zhong-dao;LUO Xue-qun(Department of Paediatrics,The First Affiliated Hospital,Sun Yat-sen University,Guangzhou 510080,China;Department of Parasitology,Zhongshan School of Medicine,Sun Yat-sen University//Key Laboratory of Tropical Disease Control,Sun Yat-sen University,Ministry of Education,Guangzhou 510080,China)
出处 《中山大学学报(医学科学版)》 CAS CSCD 北大核心 2022年第3期422-429,共8页 Journal of Sun Yat-Sen University:Medical Sciences
基金 广东省中医药局科研基金(20201056) 广东省医学科学技术研究基金(20191118191022583)。
关键词 急性白血病 细胞死亡 三氧化二砷 DNA转甲基酶1 acute leukemia cell death arsenic trioxide DNA methyltransferase 1
  • 相关文献

参考文献3

二级参考文献16

  • 1Kyo S, Takakura M, Ishikawa H, et al. Application of telomerase assay for the screening of cervical lesions. Cancer Res, 1997; 57:1863- 1867.
  • 2Nakamura TM, Morin GB, Chapman KB et al. Telomerase catalytic subunit homologs from fission yeast and human. Science, 1997;277 (5328): 955 - 959.
  • 3Viallard JF, Lacombe F, Dupory M, et al. Flow cytometry study of human cyclin B1 and cyclin E expression in leukemic cell lines:cell cycle kinetics and cell localization. Exp Cell Res, 1999; 247:208 - 219.
  • 4Holt SZ, Wright WE, Shay JW, et al. Multiple pathways for the regulation of telomerase activity. Eur J. Cancer, 1997; 33:761 -766.
  • 5Mandal M Kumar R. Bcl-2 modulates telomerase activity. J Bio Chem, 1997 ; 272:14183 - 14187.
  • 6Buchkovich KJ, Greider CW. Telomerase regulation during entry into the cell cycle in normal human T cells. Mol Bio Cell, 1996; 7:1443 - 1454.
  • 7Li H, Zhao LL, Funder JW, et al. Protein phosphatase 2A inhibits nuclear telornerase activity in human breast cancer cells. J Biol Chem, 1997 ; 272:16729 - 16732.
  • 8Kondo S, Tanaka Y, Kondo Y, et al. Antisense telomerase treatment: induction of two distinct pathways, apoptosis and differentiation. FASEB J, 1998; 12:801-811.
  • 9Shen ZX, Chen GQ, Ni JH, et al. Use of arsenic trioxide (As2O3)in the treatment of acute promyelocytic leukemia (APL) : II. Clinical efficacy and pharmacokinetics in the relapsed patients. Blood,1997; 89:3354- 3360.
  • 10Sladowski D, Streer SJ, Clothier RH, et al. An improved MTT assay. J Immunol Methods, 1993; 157:203-207.

共引文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部